Literature DB >> 12235493

Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire.

L Padua1, A Evoli, I Aprile, P Caliandro, A P Batocchi, C Punzi, S Mazza, R Padua, P Tonali.   

Abstract

We describe the development and validation of an outcome measure for patients with myasthenia gravis (MG) and show the correlation of the items with conventional MG measurements. In stage I, item generation, a group of methodologists, clinical experts generated a list of 56 items. The list was based on (1) a previous study on an MG sample, (2) clinical experience and (3) items proposed by MG patients. In stage 2, reduction of items, the list was reduced on the basis of results from field testing (41 patients completed the 56-item questionnaire). In stage 3, reliability and validity were assessed. A 25-item MG questionnaire (MGQ) was generated. Results were related to conventional measures of MG severity. Furthermore, the MGQ appeared reliable, sensitive and reproducible. The questionnaire was validated as an outcome measure.

Entities:  

Mesh:

Year:  2002        PMID: 12235493     DOI: 10.1007/s100720200027

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Development of an Elderly Low Vision Quality of Life Questionnaire for less-developed areas of China.

Authors:  Xiaoman Li; Jie Chen; Gengui Xu; Yin Zhong; Longfei Jang; Li Lin; Fan Lu
Journal:  Qual Life Res       Date:  2015-07-15       Impact factor: 4.147

2.  Evaluation of a scale of patient-reported outcomes for the assessment of myasthenia gravis patients in China.

Authors:  Feng-bin Liu; Xin-lin Chen; Li Guo; Xiao-bin Liu
Journal:  Chin J Integr Med       Date:  2012-02-27       Impact factor: 1.978

3.  The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Authors:  Ted M Burns; Mark Conaway; Donald B Sanders
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

4.  Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force.

Authors:  Marc K Walton; John H Powers; Jeremy Hobart; Donald Patrick; Patrick Marquis; Spiros Vamvakas; Maria Isaac; Elizabeth Molsen; Stefan Cano; Laurie B Burke
Journal:  Value Health       Date:  2015-08-24       Impact factor: 5.725

5.  Validation of the MG-DIS: a disability assessment for myasthenia gravis.

Authors:  Alberto Raggi; Matilde Leonardi; Silvia Schiavolin; Carlo Antozzi; Greta Brenna; Lorenzo Maggi; Renato Mantegazza
Journal:  J Neurol       Date:  2016-03-01       Impact factor: 4.849

6.  Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients.

Authors:  David Cioncoloni; Stefania Casali; Federica Ginanneschi; Marisa Carone; Boni Veronica; Alessandro Rossi; Fabio Giannini
Journal:  Neurol Sci       Date:  2016-04-01       Impact factor: 3.307

7.  Fatigue in myasthenia gravis: is it more than muscular weakness?

Authors:  Ahmed Elsais; Vegard B Wyller; Jon Håvard Loge; Emilia Kerty
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.